A detailed history of Lpl Financial LLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 53,328 shares of EDIT stock, worth $102,389. This represents 0.0% of its overall portfolio holdings.

Number of Shares
53,328
Previous 65,621 18.73%
Holding current value
$102,389
Previous $223,000 69.96%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

SELL
$1.2 - $3.76 $14,751 - $46,221
-12,293 Reduced 18.73%
53,328 $67,000
Q3 2024

Nov 08, 2024

SELL
$3.39 - $5.96 $43,049 - $75,686
-12,699 Reduced 16.21%
65,621 $223,000
Q2 2024

Aug 07, 2024

BUY
$4.67 - $7.28 $31,961 - $49,824
6,844 Added 9.58%
78,320 $365,000
Q1 2024

May 10, 2024

SELL
$7.03 - $11.07 $36,570 - $57,586
-5,202 Reduced 6.78%
71,476 $530,000
Q4 2023

Feb 14, 2024

SELL
$6.25 - $11.11 $17,462 - $31,041
-2,794 Reduced 3.52%
76,678 $776,000
Q3 2023

Nov 13, 2023

BUY
$6.92 - $9.31 $20,171 - $27,138
2,915 Added 3.81%
79,472 $619,000
Q2 2023

Jul 31, 2023

BUY
$6.36 - $11.47 $89,586 - $161,566
14,086 Added 22.55%
76,557 $630,000
Q1 2023

May 10, 2023

BUY
$7.03 - $11.53 $94,342 - $154,732
13,420 Added 27.36%
62,471 $452,000
Q4 2022

Feb 07, 2023

BUY
$8.32 - $13.21 $44,387 - $70,475
5,335 Added 12.2%
49,051 $435,000
Q3 2022

Nov 14, 2022

SELL
$12.16 - $19.42 $12,695 - $20,274
-1,044 Reduced 2.33%
43,716 $535,000
Q2 2022

Aug 12, 2022

BUY
$9.99 - $21.35 $68,241 - $145,841
6,831 Added 18.01%
44,760 $530,000
Q1 2022

May 16, 2022

SELL
$14.08 - $27.63 $79,453 - $155,916
-5,643 Reduced 12.95%
37,929 $721,000
Q4 2021

Feb 14, 2022

SELL
$26.55 - $40.57 $240,436 - $367,401
-9,056 Reduced 17.21%
43,572 $1.16 Million
Q3 2021

Nov 15, 2021

BUY
$39.27 - $72.94 $148,990 - $276,734
3,794 Added 7.77%
52,628 $2.16 Million
Q2 2021

Aug 13, 2021

SELL
$31.29 - $56.64 $503,174 - $910,827
-16,081 Reduced 24.77%
48,834 $2.77 Million
Q1 2021

May 14, 2021

BUY
$39.71 - $90.58 $206,690 - $471,468
5,205 Added 8.72%
64,915 $2.73 Million
Q4 2020

Feb 12, 2021

BUY
$27.07 - $84.35 $62,369 - $194,342
2,304 Added 4.01%
59,710 $4.19 Million
Q3 2020

Nov 09, 2020

BUY
$28.06 - $37.16 $135,922 - $180,003
4,844 Added 9.22%
57,406 $1.61 Million
Q2 2020

Aug 13, 2020

BUY
$18.5 - $34.34 $514,263 - $954,583
27,798 Added 112.25%
52,562 $1.56 Million
Q1 2020

May 14, 2020

BUY
$14.88 - $32.78 $41,574 - $91,587
2,794 Added 12.72%
24,764 $491,000
Q4 2019

Feb 14, 2020

BUY
$19.49 - $32.63 $113,743 - $190,428
5,836 Added 36.17%
21,970 $651,000
Q3 2019

Nov 13, 2019

SELL
$22.49 - $26.81 $102,239 - $121,878
-4,546 Reduced 21.98%
16,134 $367,000
Q2 2019

Aug 09, 2019

BUY
$20.48 - $27.76 $108,195 - $146,656
5,283 Added 34.31%
20,680 $512,000
Q1 2019

May 08, 2019

BUY
$19.43 - $26.41 $121,243 - $164,798
6,240 Added 68.14%
15,397 $376,000
Q4 2018

Feb 07, 2019

SELL
$18.19 - $31.79 $70,195 - $122,677
-3,859 Reduced 29.65%
9,157 $208,000
Q3 2018

Nov 14, 2018

BUY
$27.65 - $38.39 $69,678 - $96,742
2,520 Added 24.01%
13,016 $414,000
Q2 2018

Aug 14, 2018

BUY
$31.4 - $41.01 $87,480 - $114,253
2,786 Added 36.13%
10,496 $376,000
Q1 2018

May 15, 2018

BUY
$29.84 - $44.08 $230,066 - $339,856
7,710 New
7,710 $256,000

Others Institutions Holding EDIT

About Editas Medicine, Inc.


  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $132M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.